Pharma 4.0

As industries across the world are obtaining the benefits of Industry 4.0 and its technologies, pharmaceutical industry too has taken a swift step towards embracing and adopting the change which is commonly referred as Pharma 4.0. The move is aimed at digital transformation of the most important areas of pharmaceutical industry, particularly in the field of Product Development, Manufacturing and Regulatory Operations.

One of the main concerns for pharmaceutical companies is maintaining data integrity throughout the process. While many companies have started using technologies for electronic conversions and paperless submissions, some are lagging behind with the legacy technologies integrated. Without the electronic version of data sets, collating and migrating data on to virtual platforms will become a challenge for companies, which in turn will lead to difficulty in comprehensive data access and assessment. 

An additional note must be made in relation to skills and competences necessary in order to enable the digitalisation of Pharmaceutical processes successfully. Pharma 4.0 requires an extensive technical skill set to carry out operations efficiently, therefore the workforce to be deployed should possess knowledge with respect to Regulatory aspects and the technological improvements as well. As a radical improvement in the knowledge is necessary to sustain the revolution, organisations are required to build teams that are dynamic to adopt the technological transformations. 

Pharma 4.0 is here to help the medicinal product manufacturers to evolve and become more efficient and at the same time to reduce the costs. With the help of AI-based tool integration or machine language, complex processes such as those involved in Research and Development can be streamlined and expedited with minimal errors.

Internet of things (IoT), Could Computing, Artificial Intelligence (AI), Big Data are all terms which are changing the way operators function within the industry today. And the pharmaceutical industry is not immune to the radical change coming on its way. Across clinical trials, manufacturing processes, technology integrations and keeping track with ever-evolving regulations, the industry is in need of complete transformation. By adopting the modern-age technologies, companies can streamline and accelerate their processes, increase productivity and reach the global markets in an expedited, cost-effective and compliant way. 

But the question remains: how regulated are these modern-age technologies? While some of the global health authorities are taking considerable measures to regulate them, a few are still considering their viability. Without doubt, the future of the Pharmaceutical industry is shaping today towards more digital, compliant process solutions and the sooner organisations take action in favour to this change, the higher the chances to remain competitive in the long run.